Alzheimer’s Disease research is advancing with developments like Roche’s new biomarker blood test. Yet 98% of AD clinical ...

Medications like Ozempic mimic a naturally occurring hormone called glucagon-like peptide-1, or GLP-1, which helps regulate ...

For over a century, Alzheimer's disease (AD) has been considered irreversible. Consequently, research has focused on disease ...

Despite reported slowing of progression, regulators said the evidence on the novel oral agent blarcamesine did not support a ...

A major review of prior research has found no evidence that menopause hormone therapy either increases or decreases dementia ...

BBC health and science correspondent James Gallagher finds out if it is scientifically possible to ever cure Alzheimer's ...

Treatment with Kisunla was associated with sustained clinical benefits, specifically less symptom worsening and significant ...

Every year in biopharma brings its share of grueling defeats, and 2025 was no different, especially for companies targeting ...

Vaccinex, Inc. (VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating Alzheimer’s disease (AD) by inhibiting semaphorin 4D (SEMA4D) induced pathology in brain, ...

Large, well-powered Phase 1b study, designed to generate clinically and biologically meaningful insights in early Alzheimer’s diseaseClear and ...

Since its discovery, Alzheimer's disease has been considered irreversible. Consequently, research has focused on preventing ...

After seeking care for escalating memory lapses, Diane Roussel received a devastating Alzheimer's diagnosis. She began ...